Mount Sinai’s Arnhold Institute for Global Health Partners with NYC Health + Hospitals on COVID-19 Unit for Research at Elmhurst (CURE-19)

Collaboration Brings Together Clinicians and Researchers on the Front Lines of COVID-19 to Support Innovative Solutions for Health Disparities

Newswise — (New York, NY – August 12, 2020) – The Arnhold Institute for Global Health at the Icahn School of Medicine at Mount Sinai and NYC Health + Hospitals have launched the COVID-19 Unit for Research at Elmhurst (CURE-19). The new initiative will translate data, experiences, and lessons from clinicians at NYC Health + Hospitals/Elmhurst and NYC Health + Hospitals/Queens into research that will address both the pandemic and root causes of health disparities in New York City.

“The devastating impact of a pandemic can be significantly exacerbated by longstanding social, economic, and health inequities, an outcome we are seeing in communities across New York and the world,” said Dennis S. Charney, MD, the Anne and Joel Ehrenkranz Dean of the Icahn School of Medicine at Mount Sinai and President for Academic Affairs of the Mount Sinai Health System. “Through CURE-19, we are bringing together extensive resources, expertise, and reach of both the Mount Sinai Health System and Elmhurst Hospital in serving populations that are socioeconomically, demographically, and culturally diverse. The unit will explore how we can not only achieve greater success in combating COVID-19 in these communities, but also strengthen our efforts to address existing health disparities, leading to improved patient outcomes and enhanced pandemic preparedness and response initiatives.”

CURE-19 is housed within NYC Health + Hospitals/Elmhurst’s Global Health Institute and operated in partnership with the Arnhold Institute for Global Health. NYC Health + Hospitals is the largest public hospital system in the nation, serving the city’s low-income, undocumented and uninsured populations. Mount Sinai and NYC Health + Hospitals/Elmhurst have an academic affiliation agreement and joint residency programs, and previously collaborated on training, patient care and research. To date, NYC Health + Hospitals/Elmhurst has discharged more than 1,600 COVID-19 patients.

“NYC Health + Hospitals/Elmhurst and NYC Health + Hospitals/Queens serve as vital safety nets for immigrants and other underserved populations,” said Israel Rocha, Vice President of NYC Health + Hospitals and Chief Executive Officer of both facilities. “The COVID-19 pandemic dramatically revealed the extent to which socioeconomic factors and racial disparities in health care negatively impacted our patients and made them especially vulnerable to the virus. We look forward to collaborating with the Arnhold Institute for Global Health on research projects and other programs designed to eliminate these inequities.”

CURE-19 has identified three areas of urgent need in Queens to address in collaboration with leaders and experts in the borough’s communities:

· Reproductive and child healthcare: COVID-19 has added considerable stressors for pregnant women, from the fear of contracting the virus to managing birth and the first weeks of care for newborns with limited social support. CURE-19 is studying a cohort of affected women and their newborns and engaging community-based organizations to collaborate in improving the care of mothers and children.

· People living with HIV: People living with HIV experience both immune suppression and other social and economic vulnerabilities that put them at high risk for COVID-19. Drawing on extensive clinical and research expertise in shaping HIV-related care in settings including Kenya, Ethiopia, and Russia, CURE-19 is launching phone-based assessments, outreach, and clinical support for people with HIV in Kenya and New York City to evaluate the impact of the pandemic on adolescent and adult physical, mental and social health.

· Social and environmental determinants: Social and environmental factors drive the risk of COVID-19-related illness, as well as the rise in other diseases and conditions from health care disruption during the pandemic. CURE-19 is conducting a large retrospective analysis to assess the impact of air pollution, overcrowding, excessive policing, race/ethnicity, household income, and the environment on the severity of COVID-19. The unit will follow up with long-term studies to mitigate these risks, improving greater resiliency and preparedness.

“CURE-19 is informed by the insight that the true test of any health care innovation is how it impacts practice and policy, and that is what we aim to do,” said Joseph Masci, MD, Chair of Global Health at Elmhurst Hospital, Professor of Medicine (Infectious Diseases) at Mount Sinai, and a pioneer in efforts to understand AIDS, tuberculosis, bioterrorism, and Ebola. “Through our local and global work, we have developed core capacities in community-based engagement, longitudinal follow-up with specific populations, and achieving impact through changing policy, practices, and health systems that will enable us to meet the needs of the community.”

Rachel C. Vreeman, MD, MS, Chair of the Department of Global Health and Health System Design and Director of the Arnhold Institute for Global Health, said the unit will provide other health systems nationwide and internationally with guidance to enhance the quality and access to the care they deliver.

“The lessons we learn, and the data we gather, through CURE-19 will go beyond equipping us with the fundamentals to deliver more effective COVID-19 therapeutic options to vulnerable populations in New York City,” said Dr. Vreeman, a pediatrician and global health researcher with expertise in strategies to combat HIV in sub-Saharan Africa. “We can apply these lessons and the data to make fundamental changes in how we deliver health care and address the issues that have long contributed to the challenges these populations face. Our goal is to open the door to more engagement, better access and improved health outcomes among all underserved communities.”

About the Arnhold Institute for Global Health
The Arnhold Institute for Global Health at the Icahn School of Medicine at Mount Sinai specializes in global health systems and implementation research. Its global research programs and deep global partnerships generate evidence about how to build and sustain better health care systems. The institute is committed to the exchange of ideas and lessons across global and local settings facing similar challenges.

About NYC Health + Hospitals
NYC Health + Hospitals is the largest public health care system in the nation serving more than a million New Yorkers annually in more than 70 patient care locations across the city’s five boroughs. A robust network of outpatient, neighborhood-based primary and specialty care centers anchors care coordination with the system’s trauma centers, nursing homes, post-acute care centers, home care agency, and MetroPlus health plan—all supported by 11 essential hospitals. Its diverse workforce of more than 42,000 employees is uniquely focused on empowering New Yorkers, without exception, to live the healthiest life possible.

For more information, visit https://www.nychealthandhospitals.org/and stay connected on Facebook at https://www.facebook.com/NYCHealthSystemor Twitter at @NYCHealthSystem.

About the Mount Sinai Health System
The Mount Sinai Health System is New York City's largest academic medical system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai is a national and international source of unrivaled education, translational research and discovery, and collaborative clinical leadership ensuring that we deliver the highest quality care—from prevention to treatment of the most serious and complex human diseases. The Health System includes more than 7,200 physicians and features a robust and continually expanding network of multispecialty services, including more than 400 ambulatory practice locations throughout the five boroughs of New York City, Westchester, and Long Island. The Mount Sinai Hospital is ranked No. 14 on U.S. News & World Report's "Honor Roll" of the Top 20 Best Hospitals in the country and the Icahn School of Medicine as one of the Top 20 Best Medical Schools in the country. Mount Sinai Health System hospitals are consistently ranked regionally by specialty by U.S. News & World Report.

For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.

 




Filters close

Showing results

110 of 3327
Newswise: How to Keep Children Safe from COVID-19 this Fall
Released: 18-Sep-2020 4:15 PM EDT
How to Keep Children Safe from COVID-19 this Fall
Rush University Medical Center

With the new school year started and autumn approaching, Colleen Nash, MD, MPH, Rush University Medical Center, pediatric infectious disease specialist, answers questions parents may have about keeping children safe from COVID, social distancing in the classroom and celebrating Halloween.

Released: 18-Sep-2020 4:05 PM EDT
Claims circulating on social media stating that the common cold or flu can be mistaken for COVID-19 are misleading
Newswise

The claims rely on the faulty assumption that there is no method to distinguish COVID-19 from the common cold and the flu.

Released: 18-Sep-2020 3:35 PM EDT
After developing CRISPR test, UConn researchers validate clinical feasibility for COVID-19 testing
University of Connecticut

In March, researchers in the Department of Biomedical Engineering-- a shared department in the schools of Dental Medicine, Medicine, and Engineering--began to develop a new, low-cost, CRISPR-based diagnostic platform to detect infectious diseases, including HIV virus, the novel coronavirus (SARS-CoV-2).

Newswise:Video Embedded blowin-in-the-wind
VIDEO
Released: 18-Sep-2020 3:10 PM EDT
Blowin' in the wind
University of Utah

University of Utah chemical engineers have conducted an air flow study of the venue that the Utah Symphony performs in to determine the best ways to mitigate the spread of COVID-19 through the emissions of wind instrument players.

Newswise: holman1_toned-1-768x512.jpg
Released: 18-Sep-2020 2:50 PM EDT
Study links rising stress, depression in U.S. to pandemic-related losses, media consumption
University of California, Irvine

Irvine, Calif., Sept. 18, 2020 – Experiencing multiple stressors triggered by the COVID-19 pandemic – such as unemployment – and COVID-19-related media consumption are directly linked to rising acute stress and depressive symptoms across the U.S., according to a groundbreaking University of California, Irvine study. The report appears in Science Advances, published by the American Association for the Advancement of Science.

Newswise: 243389_web.jpg
Released: 18-Sep-2020 10:55 AM EDT
Potential new drug to mitigate SARS-CoV-2 infection consequences
University of Malaga

Scientists from the Department of Cell Biology of the University of Malaga (UMA) and the Andalusian Centre for Nanomedicine and Biotechnology (BIONAND) have made progress in finding new rapid implementation therapies to combat the COVID-19 pandemic, identifying a new drug that could prevent or mitigate the consequences derived from SARS-CoV-2 infection.

Newswise: 243400_web.jpg
Released: 18-Sep-2020 10:40 AM EDT
Most homemade masks are doing a great job, even when we sneeze, study finds
University of Illinois at Urbana-Champaign

Studies indicate that homemade masks help combat the spread of viruses like COVID-19 when combined with frequent hand-washing and physical distancing.

access_time Embargo lifts in 2 days
Embargo will expire: 23-Sep-2020 8:00 AM EDT Released to reporters: 18-Sep-2020 10:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 23-Sep-2020 8:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 18-Sep-2020 8:30 AM EDT
Immunotherapy Drug Development Pipeline Continues Significant Growth in 2020 Despite Global Pandemic Impact
Cancer Research Institute

Despite the impact of the COVID-19 pandemic across the globe, there has been a resurgence of interest in immuno-oncology (I-O) preclinical and clinical development, bringing hope to cancer patients and physicians who treat them.


Showing results

110 of 3327

close
1.43445